Zydus Cadila gets USFDA nod to market Baclofen tablets used to treat muscle spasm

The tablets, which come in 5 mg, help relax the muscles. Baclofen tablets will be manufactured at Zydus Cadila’s facility in Baddi, Himachal Pradesh.

FP Trending April 20, 2020 13:43:31 IST
Zydus Cadila gets USFDA nod to market Baclofen tablets used to treat muscle spasm

The United States Food and Drug Administration (USFDA) has given approval to Zydus Cadila to market Baclofen tablets which are used in the treatment of muscle spasms caused due to certain conditions such as multiple sclerosis and spinal cord injury.

Zydus Cadila gets USFDA nod to market Baclofen tablets used to treat muscle spasm

Representational image. Getty Images

The tablets, which come in 5 mg, help relax the muscles. Baclofen tablets will be manufactured at Zydus Cadila’s facility in Baddi, Himachal Pradesh.

The group now has 288 approvals and has so far filed over 386 ANDAs since the commencement of the filing process in FY 2003-04,” the company said.

Zydus Cadila had earlier on 17 April said that it had received approval from the USFDA to sell Erlotinib tablets which are used in cancer treatment. The tablets interfere with the growth of cancer cells and inhibit their spread in the body.

Erlotinib tablets are also used in the treatment of non-small cell lung cancer or pancreatic cancer which has spread to other parts of the body.

Zydus Cadila on Monday announced that it is exploring the biological route to treat novel coronavirus with long-acting Interferon alpha-2b.

“Interferon alpha-2b has been used in the treatment of COVID-19 in China and Cuba and is a part of treatment guidelines of the Chinese government,” the company said.

 

Updated Date:

also read

Explained: 'India to have world's first DNA vaccine', here's how the ZyCoV-D shot works
India

Explained: 'India to have world's first DNA vaccine', here's how the ZyCoV-D shot works

These vaccines work by inserting a piece of the virus's genetic information into the body to prompt cells to produce a key component of the virus which the immune system then recognises and attacks by producing antibodies

India logs 41,157 new coronavirus cases, 518 more deaths; active cases decline to 4,22,660
India

India logs 41,157 new coronavirus cases, 518 more deaths; active cases decline to 4,22,660

The number of people who have recovered from COVID-19 has risen to 3,02,69,796, while the case fatality rate has increased to 1.33 percent

India logs 39,361 new coronavirus cases, 416 deaths
India

India logs 39,361 new coronavirus cases, 416 deaths

Union health ministry data reveal 39,361 new coronavirus cases, 416 fresh fatalities and national COVID-19 recovery rate at 97.35 percent